Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore
1 other identifier
interventional
53
1 country
1
Brief Summary
This study is designed to develop and test an individual decision aid for pre-exposure prophylaxis (PrEP) tailored to Black women who have been exposed to intimate partner violence and are working with a domestic violence service provider. three different ways of delivering the tailored decision aid are being tested: 1) as an individual tool; or 2) as a shared decision-making tool with a domestic violence advocate; as compared to generalized information. The goal of decision aid will be to address key cultural and structural factors affecting these women and can help them gain PrEP awareness and access.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hiv
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2022
CompletedFirst Posted
Study publicly available on registry
November 14, 2022
CompletedStudy Start
First participant enrolled
May 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedAugust 22, 2025
August 1, 2025
2.2 years
November 1, 2022
August 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in HIV Risk Perception
8-item Perceived Risk of HIV scale repeated at the beginning and end of engagement with the decision aid, with responses measured on a 5- point Likert scale, which has been shown to be more robust than a single-item screening question for HIV risk perception. Specifically, responders will specify their level of agreement to the question in five points: (1) Strongly disagree; (2) Disagree; (3) Neither agree nor disagree; (4) Agree; (5) Strongly agree.
Baseline and post intervention, up to 2 minutes
Change in Decisional preference for PrEP
Single item screening question: "How interested are you in starting PrEP now?" repeated at the beginning and end of engagement with the decision aid, with responses measured on a 5- point Likert scale, with responders specify their level of agreement to the question in five points: (1) Strongly disagree; (2) Disagree; (3) Neither agree nor disagree; (4) Agree; (5) Strongly agree.
Baseline and post intervention, up to 2 minutes
Secondary Outcomes (1)
Change in PrEP Uptake
Month 1, Month 3, Month 6
Other Outcomes (4)
Change in Feelings of Decisional conflict
Baseline, Month 1, Month 3, Month 6
Process Outcomes
Month 6
Urine tenofovir levels
Month 3
- +1 more other outcomes
Study Arms (3)
Individual Arm (IDM)
EXPERIMENTALSelf-administration of the intervention
Shared Arm (SDM)
EXPERIMENTALAdvocate-administration of the intervention
Control Arm (Time and Attention Matched Control)
ACTIVE COMPARATORSelf-administration of standard PrEP information from Centers for Disease Control (CDC).
Interventions
Participant engages with the decision support tool designed to optimize PrEP uptake among Black cisgender women who have experienced IPV independently. They also enter data independently.
A video from the Centers for Disease Control and Prevention that provides basic, general information on PrEP
Domestic violence service advocate (DVA) engages with the decision support tool designed to optimize PrEP uptake among Black cisgender women who have experienced IPV with the participant and enters data
Eligibility Criteria
You may qualify if:
- age 18 years or older
- self-identification as cisgender female
- IPV-exposed (i.e., at least one physical, sexual, or psychological IPV victimization experience by a male partner) in the past 12 months
- self-reported HIV negative
- English- and/or Spanish-speaking
- self-identify as Black or African American
You may not qualify if:
- Currently using PrEP
- Unable to provide consent
- Participated in formative research for this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Bloomberg School of Public Healthlead
- Yale Universitycollaborator
Study Sites (1)
Springboard Community Services - Baltimore City Office
Baltimore, Maryland, 21209, United States
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Tiara Willie, PhD, MA
Johns Hopkins Bloomberg School of Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2022
First Posted
November 14, 2022
Study Start
May 10, 2023
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
August 22, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share